Blockchain Registration Transaction Record

Pharmaceutical Omega-3 API Market to Hit $2.3B by 2036

Pharmaceutical Omega-3 API market projected to grow from $1.1B in 2026 to $2.3B by 2036 at 7.7% CAGR. Driven by prescription cardiovascular therapies, icosapent ethyl, and regulatory-ready APIs.

This news matters because it highlights a shift from over-the-counter omega-3 supplements to prescription-grade therapies that clinically reduce cardiovascular risk. For patients, this means more effective treatments for high triglycerides and heart disease. For healthcare systems, growing reliance on purified APIs ensures consistent drug quality and regulatory compliance. Investors and pharmaceutical companies gain insights into a specialized market driven by EPA therapies and regulatory rigor, which will shape future supply chain strategies and therapeutic innovations.